1 Min Read
Oct 24 (Reuters) - Innovation Pharmaceuticals Inc
* Innovation Pharmaceuticals provides development update on Brilacidin for inflammatory bowel disease Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.